EUVIMEDEUVIMED entdecken
Crossref

Protective effects of licofelone on experimental skin flap survival rat model via cyclooxygenase and lipoxygenase inhibition: involvement of inflammatory cytokines and nitric oxide

Mahla Masoumi, Saba Ahmadi, Razieh Mohammad Jafari, Mohammad Amin Manavi, Seyed Mohammad Tavangar, Ahmad Reza Dehpour

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04304-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Mahla Masoumi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, 13145-784, Iran. Hauptthemen laut MEDLINE: Lipoxygenase Inhibitors, Nitric Oxide, Surgical Flaps, Cytokines. Die Arbeit nennt 92 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia-reperfusion injury remains a critical challenge in reconstructive surgery, often leading to extensive tissue necrosis and compromised skin flap survival. This study investigated the protective effects of licofelone, a dual cyclooxygenase and lipoxygenase inhibitor, in a rat model of random-pattern skin flap ischemia. Forty male Wistar rats underwent skin flap surgery following ischemia induction and were administered licofelone at doses of 1, 5, 10, or 20 mg/kg, with treatment given 30 min before surgery. The extent of flap necrosis was quantified 7 days postoperatively, while inflammatory markers, nitric oxide levels, and the expression of cyclooxygenase-2 and lipoxygenase-5 were assessed through enzyme-linked immunosorbent assay and western blotting. Histological evaluations were performed using hematoxylin and eosin and Masson's trichrome staining. Licofelone at 10 mg/kg significantly reduced necrosis, with a median necrotic area of 18.15% compared to 44% in the control group (p < 0.001). Treatment also markedly decreased interleukin-6, tumor necrosis factor-α, and interleukin-1β levels, as well as nitric oxide accumulation in skin tissue. Western blot analysis confirmed a significant reduction in cyclooxygenase-2 and lipoxygenase-5 expression. Histopathological analysis demonstrated reduced inflammation, epithelial degeneration, edema, and fibrosis in licofelone-treated groups. These findings highlight licofelone as a promising therapeutic agent for improving skin flap viability by modulating inflammatory and nitrergic pathways, suggesting its potential as a preoperative intervention to enhance reconstructive surgery outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoxygenase InhibitorsNitric OxideSurgical FlapsCytokinesPyrrolesReperfusion InjuryCyclooxygenase InhibitorsAnimalsMaleRats, WistarRatsSkinNecrosisDisease Models, AnimalCyclooxygenase 2Arachidonate 5-Lipoxygenase

Stichwörter der Autor:innen

CyclooxygenaseInflammationIschemia–reperfusion injuryLicofeloneLipoxygenaseNitric oxideSkin flap survival

Substanzen

Lipoxygenase InhibitorsNitric OxidelicofeloneCytokinesPyrrolesCyclooxygenase InhibitorsCyclooxygenase 2Arachidonate 5-LipoxygenasePtgs2 protein, rat

Autor:innen und Institutionen

  • Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, 13145-784, Iran.
  • Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Biotechnology, University of Science and Culture (USC), Tehran, Iran.
  • Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, 13145-784, Iran. rmjafari@sina.tums.ac.ir.
  • Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. rmjafari@sina.tums.ac.ir.
  • Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, 1416753955, Iran.

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Masoumi, M., Ahmadi, S., Mohammad Jafari, R., Manavi, M. A., Tavangar, S. M., & Dehpour, A. R. (2025). Protective effects of licofelone on experimental skin flap survival rat model via cyclooxygenase and lipoxygenase inhibition: involvement of inflammatory cytokines and nitric oxide. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04304-7

Vancouver

Masoumi M, Ahmadi S, Mohammad Jafari R, Manavi MA, Tavangar SM, Dehpour AR. Protective effects of licofelone on experimental skin flap survival rat model via cyclooxygenase and lipoxygenase inhibition: involvement of inflammatory cytokines and nitric oxide. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04304-7

BibTeX
@article{Masoumi2025,
  author = {Masoumi, Mahla and Ahmadi, Saba and Mohammad Jafari, Razieh and Manavi, Mohammad Amin and Tavangar, Seyed Mohammad and Dehpour, Ahmad Reza},
  title = {Protective effects of licofelone on experimental skin flap survival rat model via cyclooxygenase and lipoxygenase inhibition: involvement of inflammatory cytokines and nitric oxide},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04304-7}
}
Kostenlos starten →